Treatment Effectiveness
User reported effectiveness ratings Vyvanse (Adderall Family) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Attention-Deficit/Hyperactivity Disorder | 31% | 37% | 2% | 23% | 8% | 62 |
Outcomes
Below is the degree of change seen after Vyvanse (Adderall Family) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Vyvanse (Adderall Family) Info
| Property | Value |
|---|---|
| Variable Name | Vyvanse (Adderall Family) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-04-01 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 95832 |